查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601205

富血小板血漿市場：依來源類型、類型、製備方法、應用分類 - 2025-2030 年全球預測

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Type (Leukocyte-Poor PRP, Leukocyte-Rich PRP, Pure PRP), Preparation Method, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，富血小板血漿市場價值為3.8163億美元，預計到2024年將達到4.3086億美元，複合年成長率為12.09%，到2030年將達到8.4854億美元。

富血小板血漿 (PRP) 是從患者自身血液中提取的血小板濃縮物，主要用於再生醫學中以促進癒合。在應用方面，PRP廣泛應用於運動傷害的整形外科、美容手術的皮膚科、組織再生的牙科。對 PRP 的需求源於其自然癒合特性、降低免疫反應風險以及促進細胞增殖和組織修復的能力。最終用途範圍從醫院、診所和研究機構到運動醫學和美容醫學專業人士。

主要市場統計
基準年[2023] 3.8163 億美元
預測年份 [2024] 43086萬美元
預測年份 [2030] 84854萬美元
複合年成長率（%） 12.09%

主要市場促進因素包括對微創手術的需求不斷成長、患有肌肉骨骼疾病的老年人數量不斷增加以及人們對 PRP 益處的認知不斷提高。最新的商機在於PRP在抗衰老治療和女性健康領域的廣泛應用，特別是除毛和活膚治療。公司可以透過專注於改進配方、以患者為中心的方法以及與醫療保健提供者的策略夥伴關係關係來利用這些機會。然而，PRP 療法存在高成本、監管挑戰和保險範圍有限等局限性，阻礙了其廣泛使用。

影響市場的挑戰包括 PRP 配方、結果的可變性以及一些醫療相關人員對功效的懷疑。為了解決這些問題，有必要標準化 PRP 製備過程並進行廣泛的臨床測試來證實其主張。創新前景是存在的，包括開發具有增強特性、改進遞送機制的第二代 PRP 產品，以及將 PRP 與幹細胞療法等其他再生療法相結合。當我們觀察市場時，我們發現競爭非常激烈，有許多新興企業和老牌公司。想要進入這個市場的公司應該投資研發，並專注於病患教育，以增加信任和可接受性。與臨床研究學術機構的合作也將刺激該領域的創新和可信度。

市場動態：揭示快速發展的富血小板血漿市場的關鍵市場洞察

供應和需求的動態相互作用正在改變富含血小板的血漿市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 世界各地與運動相關的傷害增加
    • 應用於治療肌肉骨骼和整形外科疾病的可能性
  • 市場限制因素
    • 富血小板血漿治療效果的不確定性
  • 市場機會
    • 再生醫學的新應用
    • 擴大用於整容手術和自然癒合過程
  • 市場問題
    • 富血小板血漿產品缺乏標準化監管和報銷政策

波特五力：駕馭富血小板血漿市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解富血小板血漿市場的外部影響

外部宏觀環境因素在塑造富血小板血漿市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解富血小板血漿市場的競爭格局

對富血小板血漿市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：富血小板血漿市場供應商的績效評估

FPNV 定位矩陣是評估富血小板血漿市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製富血小板血漿市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，富血小板血漿市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球運動相關傷害的發生率正在增加
      • 應用於治療肌肉骨骼和整形外科疾病的可能性
    • 抑制因素
      • 富血小板血漿治療效果的不確定性
    • 機會
      • 再生醫學的新應用
      • 增加在整容手術和自然癒合過程中的使用
    • 任務
      • 富血小板血漿產品缺乏標準化法規和報銷政策
  • 市場區隔分析
    • 來源類型：自體 PRP 的出現，消除了疾病傳播風險並提供了高適用性
    • 類型：由於發炎反應極小，純 PRP 在美容和皮膚科治療中越來越受到青睞
    • 製備方法：擴大自動化PRP系統的實施以降低污染風險
    • 應用：由於整容手術趨勢的變化，對富血小板血漿治療的需求增加
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 富血小板血漿市場：依來源類型

  • 介紹
  • 同種異體的
  • 自體移植
  • 同源的

第7章富血小板血漿市場：依類型

  • 介紹
  • 白血球低 富含血小板血漿
  • 高白血球富血小板血漿
  • 純富血小板血漿

第8章 富血小板血漿市場：依製備方法分類

  • 介紹
  • 自動prp系統
  • 手動 PRP套件

第9章富血小板血漿市場：依應用分類

  • 介紹
  • 整容手術
  • 一般外科
  • 神經外科
  • 整形外科

第10章美洲富血小板血漿市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太富血小板血漿市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲富血小板血漿市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Terumo BCT 和 CiRA 基金會宣布突破性系統，以簡化和增強醫療 PRP 準備工作
    • Hairline International推出先進超音波PRP療法，有效促進毛髮生長
    • Plasmagen Biosciences 融資 22.5 億印度盧比用於生產血漿產品並擴大市場佔有率
    • VetStem, Inc. 推出 PrecisePRP，徹底改變方便有效的 PRP 治療的取得方式
    • FDA核准Terumo Corporation BCT 的 Revos 系統，以提高血液處理效率並滿足不斷成長的血小板需求
    • Dr. PRP USA 的富血小板血漿套件獲得 FDA 510K 醫療用途安全性和有效性許可
    • Regen Lab 的富血小板血漿解決方案獲得 CE 認證，凸顯醫療保健領域的安全性和有效性
    • 國家倫理委員會生物醫學和健康研究登記處核准新的骨髓和富血小板血漿療法，以促進癒合和康復
  • 戰略分析和建議
    • Zimmer Biomet Holdings, Inc.
    • Johnson & Johnson Services, Inc.
    • Arthrex, Inc.
    • Stryker Corporation
    • Terumo BCT, Inc.

公司名單

  • APEX Biologix
  • Arthrex, Inc.
  • Cascade Medical Wellness & Aesthetics
  • Celling Biosciences, Inc.
  • Crown Laboratories, Inc.
  • Dr PRP USA LLC
  • EmCyte Corporation
  • Estar Technologies Ltd.
  • Exactech, Inc.
  • Factor Medical, Inc.
  • Integrity PRP by Medical Buyer's Groups, LLC
  • Isto Biologics
  • Johnson & Johnson Services, Inc.
  • Juventix Regenerative Medical, LLC
  • MDBiologix
  • PRP Concepts, Inc.
  • Regen Lab SA
  • Stryker Corporation
  • Terumo BCT, Inc.
  • ThermoGenesis Holdings, Inc.
  • VetStem, Inc.
  • Ycellbio Medical Co., Ltd.
  • ZenBio, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-035AB9C0DA84

The Platelet Rich Plasma Market was valued at USD 381.63 million in 2023, expected to reach USD 430.86 million in 2024, and is projected to grow at a CAGR of 12.09%, to USD 848.54 million by 2030.

Platelet Rich Plasma (PRP) is a concentration of platelets derived from the patient's own blood and is predominantly used in regenerative medicine to accelerate healing. In terms of application, PRP is extensively used in orthopedics for sports injuries, in dermatology for cosmetic procedures, and in dentistry for tissue regeneration. The necessity for PRP arises from its natural healing properties, reduced risk of immune reactions, and ability to promote cell proliferation and tissue repair. The end-use scope spans from hospitals, clinics, and research institutions to sports and aesthetic medicine specialists.

KEY MARKET STATISTICS
Base Year [2023] USD 381.63 million
Estimated Year [2024] USD 430.86 million
Forecast Year [2030] USD 848.54 million
CAGR (%) 12.09%

Key market drivers include growing demand for minimally invasive procedures, a rising geriatric population with musculoskeletal conditions, and increasing awareness of PRP's benefits. The latest opportunities lie in the expanding applications of PRP in anti-aging treatments and women's health, particularly in treating hair loss and skin rejuvenation. Companies can capitalize on these opportunities by focusing on enhanced formulations, patient-centric approaches, and strategic partnerships with healthcare providers. However, limitations include the high cost of PRP therapy, regulatory challenges, and limited insurance coverage, which can hinder widespread adoption.

Challenges affecting the market entail variability in PRP preparations and results, as well as skepticism among some medical professionals regarding efficacy. Addressing these can involve standardizing PRP preparation processes and conducting extensive clinical trials to substantiate claims. Innovation prospects exist in developing second-generation PRP products with enhanced properties, improving delivery mechanisms, and integrating PRP with other regenerative treatments like stem cell therapy. Insight into the market suggests a competitive nature with the presence of numerous start-ups and established players. Those looking to penetrate this market should invest in research and development and maintain a focus on patient education to enhance trust and acceptance. Collaboration with academic institutions for clinical research can also spur innovation and credibility within the field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Platelet Rich Plasma Market

The Platelet Rich Plasma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of sports-related injuries globally
    • Potential application in the treatment of musculoskeletal conditions and orthopedic disorders
  • Market Restraints
    • Uncertainty on therapeutic efficacy of platelet rich plasma
  • Market Opportunities
    • Emerging application in regenerative medicine
    • Increasing use in cosmetic surgery and for natural healing process
  • Market Challenges
    • Lack of standardized regulations and reimbursement policies for platelet-rich plasma products

Porter's Five Forces: A Strategic Tool for Navigating the Platelet Rich Plasma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Platelet Rich Plasma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Platelet Rich Plasma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Platelet Rich Plasma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Platelet Rich Plasma Market

A detailed market share analysis in the Platelet Rich Plasma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Platelet Rich Plasma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Platelet Rich Plasma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Platelet Rich Plasma Market

A strategic analysis of the Platelet Rich Plasma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Platelet Rich Plasma Market, highlighting leading vendors and their innovative profiles. These include APEX Biologix, Arthrex, Inc., Cascade Medical Wellness & Aesthetics, Celling Biosciences, Inc., Crown Laboratories, Inc., Dr PRP USA LLC, EmCyte Corporation, Estar Technologies Ltd., Exactech, Inc., Factor Medical, Inc., Integrity PRP by Medical Buyer's Groups, LLC, Isto Biologics, Johnson & Johnson Services, Inc., Juventix Regenerative Medical, LLC, MDBiologix, PRP Concepts, Inc., Regen Lab SA, Stryker Corporation, Terumo BCT, Inc., ThermoGenesis Holdings, Inc., VetStem, Inc., Ycellbio Medical Co., Ltd., ZenBio, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Platelet Rich Plasma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source Type, market is studied across Allogenic, Autologous, and Homologous.
  • Based on Type, market is studied across Leukocyte-Poor PRP, Leukocyte-Rich PRP, and Pure PRP.
  • Based on Preparation Method, market is studied across Automated PRP Systems and Manual PRP Kits.
  • Based on Application, market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of sports-related injuries globally
      • 5.1.1.2. Potential application in the treatment of musculoskeletal conditions and orthopedic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on therapeutic efficacy of platelet rich plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging application in regenerative medicine
      • 5.1.3.2. Increasing use in cosmetic surgery and for natural healing process
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized regulations and reimbursement policies for platelet-rich plasma products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source Type: Emergence of autologous PRP as it eliminates the risk of disease transmission and offers high compatibility
    • 5.2.2. Type: Growing preference for pure PRP for cosmetic and dermatological treatments due to its minimized inflammatory response
    • 5.2.3. Preparation Method: Increasing adoption of automated PRP systems to reduce risk of contamination
    • 5.2.4. Application: Shifting trends toward aesthetic enhancements push need for platelet rich plasma treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Type

  • 7.1. Introduction
  • 7.2. Leukocyte-Poor PRP
  • 7.3. Leukocyte-Rich PRP
  • 7.4. Pure PRP

8. Platelet Rich Plasma Market, by Preparation Method

  • 8.1. Introduction
  • 8.2. Automated PRP Systems
  • 8.3. Manual PRP Kits

9. Platelet Rich Plasma Market, by Application

  • 9.1. Introduction
  • 9.2. Cosmetic Surgery
  • 9.3. General Surgery
  • 9.4. Neurosurgery
  • 9.5. Orthopedic Surgery

10. Americas Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Platelet Rich Plasma Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Terumo BCT and CiRA Foundation Launch Breakthrough System to Simplify and Enhance PRP Preparation for Medical Treatments
    • 13.3.2. Hairline International Launches Advanced Sonicated PRP Therapy to Boost Hair Growth Effectively
    • 13.3.3. Plasmagen Biosciences Raises INR 225 Crore to Expand Plasma Product Manufacturing and Market Presence
    • 13.3.4. VetStem, Inc. Unveils PrecisePRP to Revolutionize Access to Convenient and Effective PRP Treatments
    • 13.3.5. FDA Clears Terumo BCT's Reveos System to Improve Blood Processing Efficiency and Meet Rising Platelet Demand
    • 13.3.6. Dr. PRP USA's Platelet-Rich Plasma Kits Earn Esteemed FDA 510 K Clearance for Safety and Effectiveness in Medical Uses
    • 13.3.7. Regen Lab's Platelet Rich Plasma Solutions Earn CE Certification, Highlighting Safety, and Efficacy in Medical Treatments
    • 13.3.8. The National Ethics Committee Registry for Biomedical and Health Research Approves New Bone Marrow and Platelet-Rich Plasma Therapy to Boost Healing and Recovery
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Zimmer Biomet Holdings, Inc.
    • 13.4.2. Johnson & Johnson Services, Inc.
    • 13.4.3. Arthrex, Inc.
    • 13.4.4. Stryker Corporation
    • 13.4.5. Terumo BCT, Inc.

Companies Mentioned

  • 1. APEX Biologix
  • 2. Arthrex, Inc.
  • 3. Cascade Medical Wellness & Aesthetics
  • 4. Celling Biosciences, Inc.
  • 5. Crown Laboratories, Inc.
  • 6. Dr PRP USA LLC
  • 7. EmCyte Corporation
  • 8. Estar Technologies Ltd.
  • 9. Exactech, Inc.
  • 10. Factor Medical, Inc.
  • 11. Integrity PRP by Medical Buyer's Groups, LLC
  • 12. Isto Biologics
  • 13. Johnson & Johnson Services, Inc.
  • 14. Juventix Regenerative Medical, LLC
  • 15. MDBiologix
  • 16. PRP Concepts, Inc.
  • 17. Regen Lab SA
  • 18. Stryker Corporation
  • 19. Terumo BCT, Inc.
  • 20. ThermoGenesis Holdings, Inc.
  • 21. VetStem, Inc.
  • 22. Ycellbio Medical Co., Ltd.
  • 23. ZenBio, Inc.
  • 24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. PLATELET RICH PLASMA MARKET DYNAMICS
  • TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY LEUKOCYTE-POOR PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY LEUKOCYTE-RICH PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PURE PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOMATED PRP SYSTEMS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY MANUAL PRP KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 24. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 25. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 26. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 27. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 28. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 29. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 30. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 31. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 32. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 33. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 34. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 35. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 36. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 37. CANADA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 38. CANADA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 39. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 40. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 41. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 42. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 43. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 44. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 45. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 46. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 47. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 49. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 50. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 51. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 52. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 53. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 54. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 55. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 56. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 57. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 58. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 59. CHINA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 60. CHINA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 61. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 62. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 63. INDIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 64. INDIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 66. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 67. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 68. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 69. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 70. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 71. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 72. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 73. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 74. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 75. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 76. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 77. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 78. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 79. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 80. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 81. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 82. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 83. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 84. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 85. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 86. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 87. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 88. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 89. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 90. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 91. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 92. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 93. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 94. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 95. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 96. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 97. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 98. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 99. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 100. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 101. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 107. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 108. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 109. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 110. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 111. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 112. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 113. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 114. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 115. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 116. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 117. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 118. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 119. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 120. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 121. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 122. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 123. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 124. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 125. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 126. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 127. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 128. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 129. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 130. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 131. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 132. ITALY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 133. ITALY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 134. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 135. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 136. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 137. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 138. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 139. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 140. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 141. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 142. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 143. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 144. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 145. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 146. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 147. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 148. POLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 149. POLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 150. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 151. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 152. QATAR PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 153. QATAR PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 154. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 155. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 156. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 157. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 158. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 159. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 160. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 161. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 162. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 163. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 164. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 165. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 166. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 167. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 168. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 169. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 170. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 172. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 173. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 175. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 176. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 177. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 178. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 179. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 180. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 181. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 182. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 183. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 184. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 185. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 187. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 188. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 189. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 190. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023